Literature DB >> 2302949

Pathogenesis of colonization and infection in a neonatal surgical unit.

E M Leonard1, H K van Saene, P Shears, J Walker, P K Tam.   

Abstract

Nosocomial infection with aerobic Gram-negative bacilli is a major cause of morbidity and mortality in neonates. Few prospective studies have been undertaken in neonatal surgical units to investigate colonization and infection rates and the pathogenesis of infection. We prospectively studied 40 infants admitted to a neonatal surgical unit. Ninety-eight percent became colonized in throat/intestine with aerobic Gram-negative bacilli. Thirty-five percent developed infections, with wound and surface infections predominant (61%). Ninety-one percent of infections were caused by Gram-negative bacilli or yeasts. Severe infections (septicemia, pneumonia, meningitis) occurred in 13% of infants. The mortality rate was 5%. In all infections, the pathogenesis was found to be endogenous, and in most, three stages were distinguishable. Neonates always acquired potentially pathogenic organisms in throat/intestine (stage 1) before colonization (stage 2) and infection (stage 3) of other systems occurred. Reduction of digestive tract colonization by these potentially pathogenic microorganisms by means of successful selective decontamination may therefore reduce subsequent infection.

Entities:  

Mesh:

Year:  1990        PMID: 2302949     DOI: 10.1097/00003246-199003000-00003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Prevention of bacterial infection and sepsis in acute severe pancreatitis.

Authors:  P McClelland; A Murray; M Yaqoob; H K Van Saene; J M Bone; S M Mostafa
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

Review 2.  Selective decontamination of the digestive tract. Theoretical and practical treatment recommendations.

Authors:  S Boom; G Ramsay
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

3.  Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study.

Authors:  Enrique Cerdá; Ana Abella; Miguel A de la Cal; José A Lorente; Paloma García-Hierro; Hendrick K F van Saene; Inmaculada Alía; Ainhoa Aranguren
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

4.  Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10.

Authors:  F Nicoletti; G Mancuso; F A Ciliberti; C Beninati; M Carbone; S Franco; V Cusumano
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.

Authors:  Miguel A de La Cal; Enrique Cerdá; Paloma García-Hierro; Hendrick K F van Saene; Dulce Gómez-Santos; Eva Negro; José Angel Lorente
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 6.  Management of sepsis and septic shock in infants and children.

Authors:  N von Rosenstiel; I von Rosenstiel; D Adam
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock.

Authors:  F Genovese; G Mancuso; M Cuzzola; V Cusumano; F Nicoletti; K Bendtzen; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

8.  Selective decontamination of the digestive tract reduces pneumonia and mortality.

Authors:  Lenneke E M Haas; Marcus J Schultz
Journal:  Crit Care Res Pract       Date:  2010-10-07

9.  Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study.

Authors:  Sergey A Abudeev; Kirill V Kiselev; Nikolay M Kruglyakov; Ksenia A Belousova; Inna N Lobanova; Oleg V Parinov; Yuriy D Udalov; Maxim A Zabelin; Alexandr S Samoilov; Evaldas Cesnulis; Tim Killeen; Konstantin A Popugaev
Journal:  Front Neurol       Date:  2018-02-15       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.